CSO at Zerion, Assoc. Prof. at University of Copenhagen
Korbinian Löbmann has a strong track record in pharmaceutical formulation and drug delivery. He has 9 years of experience in solid formulation and dosage form development, including preformulation, formulation, processing and manufacturing together with the relevant solid state characterization and quality control. This includes in particular the development of new enabling formulation strategies for poorly soluble drugs using amorphous drug delivery systems. Korbinian Löbmann received his PhD in pharmaceutical sciences in 2013 from the University of Otago, New Zealand.
Title: Solubility increase of poorly soluble oral drugs using whey proteins as excipient
- Novel formulation design for poorly soluble compounds: ZERION has developed a solubility enhancing technology called Dispersomes®, which is a unique amorphous composition of small molecule drug and proteins. The Dispersome® technology provides fast dissolution, enhanced solubility and bioavailability
- Increasing drug load and amorphous stability: The Dispersome® technology outperforms existing technologies achieving higher drug loads (>50wt%) and high stability both at standard and accelerated storage conditions.